Rostislav Shevchenko

Rostislav Shevchenko

Auto-generated profile, based on publicly available information

Rostislav Shevchenko

Харківський національний медичний університет

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
ВМВіталій Макаров
Віталій Макаров
RSR.S. Shevchenko
R.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
KSK.M. Smolianyk
K.M. Smolianyk
ОPО.о. Pohorielova
О.о. Pohorielova
Combat-related thoracic trauma is a significant cause of morbidity and mortality in all military opera­tions. Penetrating, blunt, and explosive wounds are the most common mechanisms of injury. Visualization diagnosis plays a key role in the treatment. This review discusses the visualization signs of chest injuries from blunt trauma and blast trauma. Objective was to study in detail the mechanisms and visualization signs of non-penetrating combat-related thoracic trauma. 235 literature sources were found in the PubMed system by the query Thoracic AND Trauma AND Combat, 34 of which were selected for further detailed study. In modern warfare, thoracic trauma accounts for 8.6—16.0 % of casualties. Chest X-ray and CT are the visualization methods most commonly used in the evaluation of polytrauma patients from combat and peacetime. Chest X-ray can be quickly obtained in a patient with blunt trauma and emergency conditions that include tension pneumothorax, large hemothorax, chest compression, and others. Chest CT is an important component of trauma visualization. Compared to chest X-ray, chest CT identifies 20 % more pathology, and occult chest trauma due to blunt force trauma can be identified in 71 % of patients. CT provides 38—81 % additional diagnoses compared to chest X-ray.Thoracic trauma is often diagnosed in places of combat. As medical imaging technology moves closer to combat areas, this tool is becoming increasingly available to aid in the diagnosis and rapid treatment of combat-related thoracic trauma. Clinical and surgical management of the traumatized patient relies on skills learned in modern civilian training and honed in war. However, imaging of blunt and explosive injuries may be different in civilian and military settings. The distinct injury pattern and atypical imaging findings of blunt trauma and blast lung injury are important to recognize at an early stage because of the severity of this pathology and the impact of an accurate diagnosis on clinical management.We present our own observations of patients who were treated at the Military Medical Clinical Center of the Northern Region (Kharkiv) in 2022 for non­penetrating combat­related thoracic trauma.

15 June 2023 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
ВМВіталій Макаров
Віталій Макаров
RSR.S. Shevchenko
R.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
VPV.I. Petrenko
V.I. Petrenko
OPO.O. Pohorielova
O.O. Pohorielova
Мета роботи — вивчити механізми та візуалізаційні вияви проникних торакальних травм унаслідок бойових дій. Матеріали та методи. Проведено пошук джерел літератури за критерієм «Thoracic penetrating combat trauma». Відібрано 32 літературних джерела. Описаний у літературі клінічний досвід проілюстровано клінічними випадками пацієнтів, які перебували на лікуванні у медичних закладах м. Харкова у 2022 р. з приводу проникних торакальних травм унаслідок бойових дій. Результати та обговорення. У постраждалих, які отримали поранення грудної клітки, найчастіше діагностували політравму, ускладнену кількома механізмами ушкодження, пов’язаними з проникним, тупим і вибуховим пораненням. Пневмоторакс та забій легень були найпоширенішими травмами грудної клітки. Ушкодження грудної клітки, зокрема судин грудної клітки, та розриви легень були пов’язані з найвищими показниками смертності, тоді як забої легень, пневмоторакс і травми грудної стінки — з відносно нижчою смертністю. Рентгенографія органів грудної клітки є методом першої лінії візуалізації під час початкової оцінки торакальної травми в разі політравми, коли кілька смертельних ушкоджень можна швидко діагностувати для швидкого сортування та включення травми до первинного обстеження. Напружений пневмоторакс, великий гемоторакс, роздроблення грудної клітки і деякі інші ураження можна швидко діагностувати за допомогою портативної рентгенографії грудної клітки. Важливим компонентом комплексної оцінки травми є комп’ютерна томографія грудної клітки, яка дає змогу діагностувати загрозливі для життя травми у гемодинамічно стабільних пацієнтів, у яких є підозра на множинні травми, не ідентифіковані на рентгенограмі. Комп’ютерна томографія грудної клітки дає змогу ви­явити на 20 % більше патологій порівняно з рентгенографією. Висновки. Пов’язана з бойовими діями торакальна травма значно впливає на показники смертності поранених під час військових дій. Чіткий малюнок ушкодження і атипові візуалізаційні вияви торакальної травми важливо розпізнати на ранній стадії через загрозу для життя цієї категорії пацієнтів та вплив точного діагнозу на клінічне лікування. Рентгенографія грудної клітки залишається основним діагностичним засобом. Однак у сучасних та добре обладнаних установах комп’ютерна томографія органів грудної клітки, відеоасистована торакоскопія і ультразвукове сканування черевної та грудної по­­рожнини відіграють важливу роль у діагностиці торакальної травми. Швидка та якісна діагностика і лікування можливі лише при співпраці хірургів та радіологів.

29 February 2024 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
RSR.S. Shevchenko
R.S. Shevchenko
SMS.L. Matvyeyeva
S.L. Matvyeyeva
ЕTЕ. Tudor
Е. Tudor
ЄТЄ. Тудор
Є. Тудор
Establishing relationships between clinical and laboratory parameters, such as general patient’s state, parameters of complete blood count and blood biochemistry and markers of the course of tuberculosis in the future can be used to predict the severity of dysfunction of various organs and tissues in patients with tuberculosis and in particular in patients who receive anti-tuberculosis treatment. Objective — to investigate the relationship between biochemical markers, namely Human-beta-defensin-1, ferritin and interleukin-6, and clinical and laboratory indicators of the severity of the tuberculosis process. Materials and methods. 100 patients diagnosed with pulmonary tuberculosis were included in the study. After receiving 60 doses of anti-tuberculosis treatment, the patients were retrospectively divided into 2 groups. Group 1 (n = 77) consisted of patients in whom sputum conversion was observed after 60 doses of treatment, determined by sputum microscopy. Group 2 (n = 23) comprised patients in whom bacterial secretion was maintained after 60 doses of treatment, as detected by microscopy. In addition to the routine studies provided for the monitoring of patients with tuberculosis by the current orders of the Ministry of Health of Ukraine, the levels of Human-beta-defensin-1, ferritin and interleukin-6 (IL-6) in the fasting blood were additionally measured by ELISA at the beginning of treatment and after 60 days. Statistical data processing was carried out using the Statistica 8.0 software environment. Results. A comparison of the investigated parameters between groups at the beginning of treatment showed significantly higher values of Human-beta-defensin-1 (Group 1 — (18.97 ± 2.42) pg/ml, Group 2 — (55.02 ± ± 15.69) pg/ml), ferritin (Group 1 — (94.86 ± 6.02) ng/ml, Group 2 — (141.61 ± 24.66) ng/ml) and IL-6 (Group 1 — (80.33 ± 5.03) pg/ml, Group 2 — (110.13 ± 10.35) pg/ml) in patients with positive sputum micros­copy after 60 doses of treatment, p < 0.05. All studied markers demonstrated a reliable positive relationship with the massiveness of bacterial excretion, a conditional indicator of the severity of clinical symptoms and signs, ESR and urea level, as well as reliable negative correlations with creatinine level. In addition, patients with a lower body mass index were found to have higher levels of Human-beta-defensin-1 and ferritin. Higher levels of Human-beta-defensin-1 and ferritin are associated with lower hemoglobin levels (Human-beta-defensin-1 was also negatively correlated with erythrocyte count). An increase in the leukocytes level is accompanied by a significant increase in the level of Human-beta-defensin-1 and IL-6. Additionally, a significant negative correlation was found between the level of glucose and ferritin, as well as between the level of bilirubin and ferritin and IL-6. Conclusions. The determined significantly higher levels of Human-beta-defensin-1, ferritin and interleukin-6 in patients in whom sputum microscopy was positive after 60 doses of treatment allow considering the investigated biochemical parameters as markers of the ineffectiveness of anti-tuberculosis therapy. The identified positive relationships with the severity of clinical symptoms indicate the possibility of using the studied parameters as markers of the severity of the tuberculosis course. The possibility of using Human-beta-defensin-1 and ferritin as markers of anemia was also found. Correlations with parameters of blood biochemistry allow us to talk about increased levels of Human-beta-defensin-1, ferritin and interleukin-6 against the background of kidney damage. - Установлення зв’язків між клініко-лабораторними параметрами (загальний стан пацієнта, показники клінічного і біохімічного аналізів крові) та маркерами перебігу туберкульозу в перспективі може бути використане для прогнозування тяжкості порушення функціонування різних органів і тканин у хворих на туберкульоз, зокрема в пацієнтів, які отримують протитуберкульозне лікування.Мета роботи — дослідити зв’язки між біохімічними маркерами (β-дефензин-1, феритин, інтерлейкін-6 (ІЛ-6)) і клінічними та лабораторними показниками тяжкості туберкульозного процесу. Матеріали та методи. У дослідження було залучено 100 хворих на туберкульоз легень. Після отримання 60 доз протитуберкульозного лікування пацієнтів ретроспективно розподілили на дві групи: 77 пацієнтів, у яких зареєстрували припинення бактеріовиділення (за даними мікроскопії мокротиння), і 23 пацієнти, у яких зберігалося бактеріовиділення (за даними мікроскопії мокротиння). Крім рутинних досліджень, передбачених для моніторингу пацієнтів із туберкульозом наказами МОЗ України щодо ведення хворих на туберкульоз, вимірювали рівень β-дефензину-1, феритину та ІЛ-6 у крові натще методом імуноферментного аналізу на початку лікування та через 60 днів. Статистичну обробку даних проведено за допомогою програмного...

30 October 2025 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
VPV.I. Petrenko
V.I. Petrenko
RSR.S. Shevchenko
R.S. Shevchenko
IOI.A. Ovcharenko
I.A. Ovcharenko
OPO.O. Pohorielova
O.O. Pohorielova
Modern patterns of terrorist activity and military operations worldwide have increased the potential casualties associated with explosions. However, few civilian doctors have experience in the treatment of patients with blast injuries, which highlights the need to improve knowledge about the physics, patho­genesis of blast injury and other associated types of injuries that may occur. Objective — to describe the main mechanisms of blast lung injury development and algorithms for the diagnosis and clinical management of such patients. Materials and methods. A total of 528 literature sources in the PubMed database were analysed for the key words «Blast lung injury» and 35 of them were selected for detailed further analysis. Results and discussion. Blast lung injury is a major cause of morbidity and mortality in explosion victims both at the scene and among the first survivors. Blast impact on the lungs results in rupture, haemorrhage, contusion and oedema, with subsequent ventilation-perfusion disorders. Blast lung injury is a clinical diagnosis characterised by respiratory distress and hypoxia, which may occur without apparent external chest injury. Conclusions. Blast lung injury is one of the most common causes of death in blast victims. Blast injuries should be managed by a multidisciplinary team that includes a trauma surgeon, general surgeon, ENT specialist, ophthalmologist, plastic surgeon, anaesthesiologist, intensive care physician and emergency department physician, and other specialists as needed. Mental health counselling is also recommended for these patients, as the development of acute stress disorder, adjustment disorders and post-traumatic stress disorder cannot be ruled out. If the injury is minor, the patient can be observed for 6—8 hours and discharged. However, all serious blast injuries require hospitalisation and monitoring; in addition, they have an extended rehabilitation phase.

22 May 2024 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
RSR.S. Shevchenko
R.S. Shevchenko
SMS.L. Matvyeyeva
S.L. Matvyeyeva
IOI.A. Ovcharenko
I.A. Ovcharenko
OPO.O. Pohorielova
O.O. Pohorielova
Objective — to explore the correlation between the levels of Human-beta-defensin-1, ferritin and Interleu­kin-6 and the spectrum of drug resistance, as well as the treatment regimens in patients with pulmonary tuberculosis. Materials and methods. This study included 100 patients with pulmonary tuberculosis, divided into two groups: Group 1 (n = 52) with drug-susceptible tuberculosis and Group 2 (n = 48) with drug-resistant tuber­culosis, including patients with multidrug-resistant (MDR-TB) and pre-extensively drug-resistant tuberculosis. Diagnostic assessments included chest X-rays and sputum examinations using microscopic, molecular-genetic and cultural methods. Levels of HBD-1, ferritin and IL-6 were measured using ELISA on fasting blood samples at the onset of treatment and after 60 days. Data analysis was performed using Statistica 8.0 software. Results and discussion. In patients with drug-susceptible tuberculosis, the initial levels of biomarkers were significantly higher compared to their levels after 60 treatment doses. Specifically, Human-beta-defensin-1 (HBD-1) decreased from (23.38 ± 3.48) pg/mL initially to (11.83 ± 2.30) pg/mL after 60 doses; ferritin decreased from (117.47 ± 12.34) ng/mL to (85.74 ± 13.25) ng/mL; and Interleukin-6 (IL-6) decreased from (87.49 ± 8.43) pg/mL to (51.37 ± 5.15) pg/mL. Conversely, in patients with drug-resistant tuberculosis, while IL-6 levels also showed a significant decrease from (99.78 ± 8.52) pg/mL at the onset to (67.59 ± 8.28) pg/mL after 60 doses, both HBD-1 and ferritin levels increased post-treatment. HBD-1 levels rose from (21.43 ± 4.39) pg/mL to (30.69 ± 5.06) pg/mL, and ferritin levels from (105.13 ± 8.72) ng/mL to (153.43 ± 20.29) ng/mL. Conclusions. In patients with drug-susceptible tuberculosis, levels of HBD-1, ferritin and IL-6 significantly decrease after 60 days of treatment. This decrease correlates with a reduction in clinical and radiographic symptoms of tuberculosis and the cessation of bacterial excretion. Conversely, in patients with drug-resistant tuberculosis, levels of HBD-1 and ferritin increase after 60 doses of treatment, likely due to a delayed reduction in bacterial load and a prolonged active immune response. However, IL-6 levels significantly decrease, suggesting its primary role in initiating the anti-tuberculosis immune response. The lack of significant differences in these biomarkers between patients with drug-susceptible and drug-resistant tuberculosis at the onset of treatment suggests that drug resistance does not inherently affect the severity of tuberculosis inflammation or the activity of the initial anti-tuberculosis immune response.

1 January 2026 in SCRIPTA MEDICA
Verified
Journal Article
Open access
PDF file
ВМВіталій Макаров
Віталій Макаров
SPSergey Pavlov
Sergey Pavlov
RSRostislav Shevchenko
Rostislav Shevchenko
VFVolodymyr Feskov
Volodymyr Feskov
MKMarina Kumetchko
Marina Kumetchko
OLOlga Litvinova
Olga Litvinova
Gunshot wounds remain one of the most complex types of combat injuries. A gunshot wound is a dynamic system in which the initial mechanical destruction of tissue is only the starting point of a complex and multi-level process. Subsequently, the wound site steadily transforms and the volume of non-viable tissue increases, spreading beyond the wound channel area. This review examines the pathogenesis of a gunshot wound, which is a chain of cause-and-effect changes in which each link is formed as a direct consequence of previous disturbances. The pathophysiological events that contribute to the chronic wound process are identified, which cannot be interrupted by natural mechanisms.